共 102 条
[1]
Polack FP(2020)Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine N Engl J Med 383 2603-2615
[2]
Thomas SJ(2022)Safety and efficacy of a third dose of BNT162b2 Covid-19 vaccine N Engl J Med 386 1910-1921
[3]
Kitchin N(2021)Protection of BNT162b2 vaccine booster against Covid-19 in Israel N Engl J Med 385 1393-1400
[4]
Moreira ED(2022)Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression Lancet 399 924-944
[5]
Kitchin N(2022)Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19-associated hospitalization among immunocompetent adults aged ≥ 65 years—IVY network, 18 States, September 8-November 30, 2022 MMWR Morb Mortal Wkly Rep 71 1625-1630
[6]
Xu X(2022)Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19-associated emergency department or urgent care encounters and hospitalizations among immunocompetent adults—VISION network, Nine States, September-November 2022 MMWR Morb Mortal Wkly Rep 71 1616-1624
[7]
Bar-On YM(2023)Estimates of bivalent mRNA vaccine durability in preventing COVID-19-associated hospitalization and critical illness among adults with and without immunocompromising conditions—VISION Network, September 2022-April 2023 MMWR Morb Mortal Wkly Rep 72 579-588
[8]
Goldberg Y(2022)How seasonality and control measures jointly determine the multistage waves of the COVID-19 epidemic: a modelling study and implications Int J Environ Res Public Health 19 6404-1441
[9]
Mandel M(2023)Seasonal trends in COVID-19 cases, hospitalizations, and mortality in the United States and Europe Sci Rep 13 3886-A14
[10]
Feikin DR(2022)Interim recommendations from the Advisory Committee on Immunization Practices for the use of bivalent booster doses of COVID-19 vaccines—United States, October 2022 MMWR Morb Mortal Wkly Rep 71 1436-28